Nationwide Fund Advisors Alaunos Therapeutics, Inc. Transaction History
Nationwide Fund Advisors
- $918 Million
- Q2 2024
Shares
3 transactions
Others Institutions Holding TCRT
# of Institutions
5Shares Held
92.6KCall Options Held
0Put Options Held
0-
Gamble Jones Investment Counsel61KShares$160,4300.0% of portfolio
-
Altium Wealth Management LLC15KShares$39,4500.0% of portfolio
-
Sawtooth Solutions, LLC14.3KShares$37,4770.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.1KShares$5,5230.0% of portfolio
-
Trustcore Financial Services, LLC250Shares$6570.0% of portfolio
About Alaunos Therapeutics, Inc.
- Ticker TCRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,182,000
- Market Cap $569M
- Description
- Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...